Table 1.
Peptide | Sequence | Derivation | Total # of charged residues |
Cargo | Alternative Classification |
---|---|---|---|---|---|
HIV-1 TAT49–5774,93 | RKKRRQRRR | Human Immunodeficiency Virus | 8 | protein, peptides, siRNA | Non-amphipathic |
Penetratin94 | RQIKIWFQNRRMKWKK | Drosophila homeoprotein antennapedia | 7 | protein, PNA, siRNA | Secondary amphipathic |
pVEC95 | LLIILRRRIRKQAHAHSK | Murine VE-cadherin | 6 | protein, peptides | Secondary amphipathic |
VP2296 | NAKTRRHERRRKLAIER | Herpes simplex virus | 8 | protein | Secondary amphipathic |
Pep-190–92,97 | KETWWETWWTEWSQPKKKRKV | NLS from SV40 T-antigen and a Tryptophan-rich domain | 5 | protein, peptides | Primary amphipathic |
MPG91,98,99 | GALFLGFLGAAGSTMGAWSQPKKKRKV | Hydrophbic domain from fusion sequence of HIV gp41 and NLS of SV40 T-antigen | 5 | siRNA, plasmids | Primary amphipathic |
Transportan (TP10)100,101 | AGYLLGKINLKALAALAKKIL | Galanin and mastoparan | 4 | protein, PNA, siRNA | Primary amphipathic |
M918102 | MVTVLFRRLRIRRACGPPRVRV | Tumor suppressor protein p14ARF | 7 | Proteins, PNA | Secondary amphipathic |
YTA2103 | YTAIAWVKAFIRKLRK | MMP cleavage site | 5 | small molecules | Secondary amphipathic |
YTA4103 | IAWVKAFIRKLRKGPLG | MMP cleavage site | 5 | small molecules | Secondary amphipathic |
MAP104,105 | KLALKLALKALKAALKLA | Synthetic | 5 | small molecules, plasmids | Secondary amphipathic |
Polyarginine83,84,89,106 | R5–15 | HIV-1 TAT | 5–15 | protein, peptides, siRNA | Non-amphipathic |
CADY107,108 | GLWRALWRLLRSLWRLLWRA | Derived from PPTG1 peptide | 5 | protein, peptides, siRNA | Secondary amphipathic |